Stk39tm2.1Arte
Targeted Allele Detail
|
Symbol: |
Stk39tm2.1Arte |
Name: |
serine/threonine kinase 39; targeted mutation 2.1, TaconicArtemis |
MGI ID: |
MGI:5770425 |
Synonyms: |
SPAKL502A |
Gene: |
Stk39 Location: Chr2:68040789-68302381 bp, - strand Genetic Position: Chr2, 39.53 cM, cytoband C3
|
Alliance: |
Stk39tm2.1Arte page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:224087
|
Parent Cell Line: |
Not Specified (ES Cell)
|
Strain of Origin: |
Not Specified
|
|
Allele Type: |
|
Targeted |
Mutations: |
|
Insertion, Nucleotide substitutions
|
|
|
Mutation details: Exon 16 was replaced with a modified exon 16 in which nucleotide substitutions result in the amino acid substitution of alanine for leucine at position 502 (L502A) in the conserved carboxy-terminal (CCT) domain. Flp-mediated recombination removed an FRT-flanked puromycin cassette inserted in intron 15. This mutation suppresses protein phosphorylation by WNK isoforms and results in markedly reduced phosphorylation and expression of sodium ion co-transporters NCC and NKCC2 in the kidney.
(J:224087)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Stk39 Mutation: |
42 strains or lines available
|
|
Original: |
J:224087 Zhang J, et al., Critical role of the SPAK protein kinase CCT domain in controlling blood pressure. Hum Mol Genet. 2015 Aug 15;24(16):4545-58 |
All: |
2 reference(s) |
|